Degeneration of the Pericryptal Myofibroblast Sheath by Proinflammatory Cytokines in Inflammatory Bowel Diseases

Gastroenterology

Volumn 136, Issue 1, 2009, Pages

  Francoeur, Caroline ^a   Bouatrouss, Yamina ^a   Seltana, Amira ^a   Pinchuk, Iryna V ^b   Vachon, Pierre H ^a   Powell, Don W ^b   Sawan, Basem ^a   Seidman, Ernest G ^a,c   Beaulieu, Jean François ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b University of Texas Medical Branch School of Medicine   (United States)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; DESMIN; GAMMA INTERFERON; INTERLEUKIN 1BETA; TENASCIN; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

APOPTOSIS; ARTICLE; COLON CROHN DISEASE; CONTROLLED STUDY; CRYPT CELL; ENTERITIS; HUMAN; HUMAN TISSUE; INTESTINE CELL; MYOFIBROBLAST; PRIORITY JOURNAL; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECT; FIBROBLAST; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; PATHOLOGY; PHYSIOLOGY;

APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINES; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASES; INTERFERON-GAMMA; INTESTINAL MUCOSA; TENASCIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 59849091302     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.10.014     Document Type: Article

References (43)

1. Korzenik J.R., and Podolsky D.K. Evolving knowledge and therapy of inflammatory bowel disease. Nat Rev Drug Discov 5 (2006) 197-209
2. Macdonald T.T., and Monteleone G. Immunity, inflammation, and allergy in the gut. Science 307 (2005) 1920-1925
3. Sartor R.B. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 3 (2006) 390-407
4. Bouma G., and Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3 (2003) 521-533
5. Newman B., and Siminovitch K.A. Recent advances in the genetics of inflammatory bowel disease. Curr Opin Gastroenterol 21 (2005) 401-407
6. Bruewer M., Samarin S., and Nusrat A. Inflammatory bowel disease and the apical junctional complex. Ann N Y Acad Sci 1072 (2006) 242-252
7. Fiocchi C. Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions. Am J Physiol 273 (1997) G769-G775
8. Dionne S., Ruemmele F.M., and Seidman E.G. Immunopathogenesis of inflammatory bowel disease: role of cytokines and immune cell-enterocyte interactions. Nestle Nutr Workshop Ser Clin Perform Programme 2 (1999) 41-61
9. McKay D.M., and Baird A.W. Cytokine regulation of epithelial permeability and ion transport. Gut 44 (1999) 283-289
10. Begue B., Wajant H., Bambou J.C., et al. Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions. Gastroenterology 130 (2006) 1962-1974
11. Francoeur C., Escaffit F., Vachon P.H., et al. Proinflammatory cytokines TNF-alpha and IFN-gamma alter laminin expression under an apoptosis-independent mechanism in human intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 287 (2004) G592-G598
12. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200 (2003) 500-503
13. Sappino A.P., Schurch W., and Gabbiani G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 63 (1990) 144-161
14. Vallance B.A., Gunawan M.I., Hewlett B., et al. TGF-beta1 gene transfer to the mouse colon leads to intestinal fibrosis. Am J Physiol Gastrointest Liver Physiol 289 (2005) G116-G128
15. Powell D.W., Adegboyega P.A., Di Mari J.F., et al. Epithelial cells and their neighbors I. Role of intestinal myofibroblasts in development, repair, and cancer. Am J Physiol Gastrointest Liver Physiol 289 (2005) G2-G7
16. Powell D.W., Mifflin R.C., Valentich J.D., et al. Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am J Physiol 277 (1999) C183-C201
17. Riedl S.E., Faissner A., Schlag P., et al. Altered content and distribution of tenascin in colitis, colon adenoma, and colorectal carcinoma. Gastroenterology 103 (1992) 400-406
18. Otte J.M., Rosenberg I.M., and Podolsky D.K. Intestinal myofibroblasts in innate immune responses of the intestine. Gastroenterology 124 (2003) 1866-1878
19. Saada J.I., Pinchuk I.V., Barrera C.A., et al. Subepithelial myofibroblasts are novel nonprofessional APCs in the human colonic mucosa. J Immunol 177 (2006) 5968-5979
20. Ménard D., Beaulieu J.-F., Boudreau F., et al. Gastrointestinal tract. In: Unsicker K., and Krieglstein K. (Eds). Cell signaling and growth factors in development: from molecules to organogenesis Vol 2 (2006), Wiley-Vch, Weinheim 755-790
21. Kruidenier L., MacDonald T.T., Collins J.E., et al. Myofibroblast matrix metalloproteinases activate the neutrophil chemoattractant CXCL7 from intestinal epithelial cells. Gastroenterology 130 (2006) 127-136
22. McKaig B.C., McWilliams D., Watson S.A., et al. Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease. Am J Pathol 162 (2003) 1355-1360
23. Beaulieu J.F. Extracellular matrix components and integrins in relationship to human intestinal epithelial cell differentiation. Prog Histochem Cytochem 31 (1997) 1-78
24. Teller I., and Beaulieu J.F. Interactions between laminin and epithelial cells in intestinal health and disease. Exp Rev Mol Med 28 (2001). http://www.expertreviews.org/01003623h.htm September, http://www.expertreviews.org/01003623h.htm
25. Bouatrouss Y., Herring-Gillam F.E., Gosselin J., et al. Altered expression of laminins in Crohn's disease small intestinal mucosa. Am J Pathol 156 (2000) 45-50
26. Beaulieu J.F., and Vachon P.H. Reciprocal expression of laminin A-chain isoforms along the crypt-villus axis in the human small intestine. Gastroenterology 106 (1994) 829-839
27. Dydensborg A.B., Herring E., Auclair J., et al. Normalizing genes for quantitative RT-PCR in differentiating human intestinal epithelial cells and adenocarcinomas of the colon. Am J Physiol Gastrointest Liver Physiol 290 (2006) G1067-G1074
28. Vachon P.H., Durand J., and Beaulieu J.F. Basement membrane formation and re-distribution of the beta 1 integrins in a human intestinal co-culture system. Anat Rec 235 (1993) 567-576
29. Mahida Y.R., Beltinger J., Makh S., et al. Adult human colonic subepithelial myofibroblasts express extracellular matrix proteins and cyclooxygenase-1 and -2. Am J Physiol 273 (1997) G1341-G1348
30. Pinchuk I.V., Beswick E.J., Saada J.I., et al. Monocyte chemoattractant protein-1 production by intestinal myofibroblasts in response to staphylococcal enterotoxin a: relevance to staphylococcal enterotoxigenic disease. J Immunol 178 (2007) 8097-8106
31. Ruemmele F.M., Dionne S., Levy E., et al. TNFalpha-induced IEC-6 cell apoptosis requires activation of ICE caspases whereas complete inhibition of the caspase cascade leads to necrotic cell death. Biochem Biophys Res Commun 260 (1999) 159-166
32. Bélanger I., and Beaulieu J.F. Tenascin in the developing and adult human intestine. Histol Histopathol 15 (2000) 577-585
33. Ruemmele F.M., Russo P., Beaulieu J., et al. Susceptibility to FAS-induced apoptosis in human nontumoral enterocytes: role of costimulatory factors. J Cell Physiol 181 (1999) 45-54
34. Teller I.C., Auclair J., Herring E., et al. Laminins in the developing and adult human small intestine: relation with the functional absorptive unit. Dev Dyn 236 (2007) 1980-1990
35. Lawrance I.C., Maxwell L., and Doe W. Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease. Inflamm Bowel Dis 7 (2001) 226-236
36. Wang F., Schwarz B.T., Graham W.V., et al. IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterology 131 (2006) 1153-1163
37. Marini M., Bamias G., Rivera-Nieves J., et al. TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis. Proc Natl Acad Sci U S A 100 (2003) 8366-8371
38. Van den Brande J.M., Koehler T.C., Zelinkova Z., et al. Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease. Gut 56 (2007) 509-517
39. Brittan M., Alison M.R., Schier S., et al. Bone marrow stem cell-mediated regeneration in IBD: where do we go from here?. Gastroenterology 132 (2007) 1171-1173
40. Andoh A., Bamba S., Fujiyama Y., et al. Colonic subepithelial myofibroblasts in mucosal inflammation and repair: contribution of bone marrow-derived stem cells to the gut regenerative response. J Gastroenterol 40 (2005) 1089-1099
41. Desmouliere A., Rubbia-Brandt L., Abdiu A., et al. Alpha-smooth muscle actin is expressed in a subpopulation of cultured and cloned fibroblasts and is modulated by gamma-interferon. Exp Cell Res 201 (1992) 64-73
42. Fiocchi C. TGF-beta/Smad signaling defects in inflammatory bowel disease: mechanisms and possible novel therapies for chronic inflammation. J Clin Invest 108 (2001) 523-526
43. Simmons J.G., Pucilowska J.B., Keku T.O., et al. IGF-I and TGF-beta1 have distinct effects on phenotype and proliferation of intestinal fibroblasts. Am J Physiol Gastrointest Liver Physiol 283 (2002) G809-G818